Preaddiction—a missing concept for treating substance use disorders

AT McLellan, GF Koob, ND Volkow - JAMA psychiatry, 2022 - jamanetwork.com
Background The centuries-old term addiction remains widely used in both professional and
popular media because it communicates commonly held imagery of those whose once …

Therapeutic potential of ketamine for alcohol use disorder

SD Worrell, TJ Gould - Neuroscience & Biobehavioral Reviews, 2021 - Elsevier
Excessive alcohol consumption is involved in 1/10 of deaths of US working-age adults and
costs the country around $250,000,000 yearly. While Alcohol Use Disorder (AUD) pathology …

Association of pregnancy and insurance status with treatment access for opioid use disorder

SW Patrick, MR Richards, WD Dupont… - JAMA network …, 2020 - jamanetwork.com
Importance Medications for opioid use disorder, including buprenorphine hydrochloride and
methadone hydrochloride, are highly effective at improving outcomes for individuals with the …

[HTML][HTML] Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: a US …

S Amiri, MG McDonell, JT Denney, D Buchwald… - Value in Health, 2021 - Elsevier
Objectives To measure access to opioid treatment programs (OTPs) and office-based
buprenorphine treatment (OBBTs) at the smallest geographic unit for which the Census …

State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies

J Xu, CS Davis, M Cruz, P Lurie - Drug and alcohol dependence, 2018 - Elsevier
Background In response to the ongoing opioid overdose epidemic, many states have
enacted laws increasing naloxone access by lay people, such as friends and family …

Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?

M Antonelli, L Sestito, C Tarli, G Addolorato - European Journal of Internal …, 2022 - Elsevier
Introduction In the last decades, many medications have been tested for the treatment of
Alcohol Use Disorder (AUD). Among them, disulfiram, acamprosate, naltrexone, nalmefene …

American Academy of Nursing Expert Panel Consensus Statement on leveraging equity in policy to improve recognition and treatment of mental health, substance use …

JE Schimmels, C Groh, M Neft, L Wocial, C Young… - Nursing outlook, 2023 - Elsevier
Rates of nurse mental health and substance use disorders are high. Heightened by the
COVID-19 pandemic, nurses are challenged to care for patients in ways that often …

Microbial short-chain fatty acids regulate drug seeking and transcriptional control in a model of cocaine seeking

KR Meckel, SS Simpson, A Godino, EG Peck… - …, 2024 - nature.com
Cocaine use disorder represents a public health crisis with no FDA-approved medications
for its treatment. A growing body of research has detailed the important connections …

Buprenorphine diffusion: The attitudes of substance abuse treatment counselors

HK Knudsen, LJ Ducharme, PM Roman… - Journal of substance abuse …, 2005 - Elsevier
In October 2002, the Food and Drug Administration approved buprenorphine for use in the
treatment of opioid dependence. Successful diffusion, adoption, and implementation of this …

Rx for addiction and medication safety: An evaluation of teen education for opioid misuse prevention

E Patry, JP Bratberg, A Buchanan, AL Paiva… - Research in Social and …, 2019 - Elsevier
Abstract Background Rhode Island (RI) ninth graders report lifetime nonmedical use of
prescription opioids (NMUPO) of 8.9%. NMUPO is associated with transition to heroin use …